BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $209,000 | -67.2% | 2,691 | -63.7% | 0.01% | -60.0% |
| Q4 2021 | $637,000 | -38.9% | 7,422 | -42.7% | 0.02% | -34.8% |
| Q3 2021 | $1,042,000 | +2.6% | 12,960 | +2.7% | 0.02% | 0.0% |
| Q2 2021 | $1,016,000 | -6.7% | 12,623 | -2.3% | 0.02% | -11.5% |
| Q1 2021 | $1,089,000 | -2.9% | 12,914 | -7.6% | 0.03% | -7.1% |
| Q4 2020 | $1,121,000 | -8.3% | 13,973 | -8.1% | 0.03% | -17.6% |
| Q3 2020 | $1,223,000 | -26.3% | 15,209 | -21.1% | 0.03% | -29.2% |
| Q2 2020 | $1,660,000 | +5.5% | 19,282 | -0.6% | 0.05% | -11.1% |
| Q1 2020 | $1,574,000 | -4.7% | 19,391 | -1.8% | 0.05% | +20.0% |
| Q4 2019 | $1,651,000 | -3.6% | 19,741 | +0.9% | 0.04% | -8.2% |
| Q3 2019 | $1,712,000 | +2.1% | 19,571 | -4.3% | 0.05% | +6.5% |
| Q2 2019 | $1,676,000 | -24.0% | 20,458 | -24.6% | 0.05% | -32.4% |
| Q1 2019 | $2,205,000 | +24.4% | 27,116 | +0.7% | 0.07% | +11.5% |
| Q4 2018 | $1,772,000 | +2.7% | 26,931 | +20.4% | 0.06% | +15.1% |
| Q3 2018 | $1,725,000 | -3.6% | 22,375 | -7.7% | 0.05% | +15.2% |
| Q2 2018 | $1,790,000 | +12.6% | 24,242 | -0.8% | 0.05% | -8.0% |
| Q1 2018 | $1,590,000 | -2.7% | 24,446 | -3.3% | 0.05% | -2.0% |
| Q4 2017 | $1,634,000 | +0.7% | 25,269 | -2.3% | 0.05% | -5.6% |
| Q3 2017 | $1,622,000 | -8.8% | 25,852 | -11.9% | 0.05% | -10.0% |
| Q2 2017 | $1,778,000 | +25.2% | 29,355 | +7.3% | 0.06% | +20.0% |
| Q1 2017 | $1,420,000 | -16.1% | 27,361 | -28.3% | 0.05% | -20.6% |
| Q4 2016 | $1,693,000 | -1.3% | 38,168 | +6.0% | 0.06% | -30.0% |
| Q3 2016 | $1,715,000 | +1.5% | 36,024 | -3.6% | 0.09% | -1.1% |
| Q2 2016 | $1,690,000 | +6.0% | 37,365 | -3.7% | 0.09% | +7.1% |
| Q1 2016 | $1,595,000 | +6.6% | 38,804 | -1.0% | 0.08% | +7.6% |
| Q4 2015 | $1,496,000 | +8.6% | 39,198 | -6.5% | 0.08% | +1.3% |
| Q3 2015 | $1,377,000 | -53.2% | 41,911 | -0.4% | 0.08% | -49.7% |
| Q2 2015 | $2,942,000 | +13.9% | 42,076 | +11.6% | 0.16% | +18.3% |
| Q1 2015 | $2,583,000 | -3.9% | 37,702 | +2.8% | 0.13% | -4.4% |
| Q4 2014 | $2,687,000 | +3.2% | 36,658 | +1.0% | 0.14% | -0.7% |
| Q3 2014 | $2,604,000 | -4.0% | 36,280 | -3.3% | 0.14% | -4.2% |
| Q2 2014 | $2,712,000 | +24.7% | 37,512 | +26.9% | 0.14% | +10.8% |
| Q1 2014 | $2,175,000 | +31.0% | 29,552 | +23.9% | 0.13% | +36.8% |
| Q4 2013 | $1,660,000 | +16.0% | 23,853 | +9.5% | 0.10% | +4.4% |
| Q3 2013 | $1,431,000 | -41.8% | 21,793 | -38.6% | 0.09% | -43.1% |
| Q2 2013 | $2,459,000 | – | 35,504 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |